Evidence map›Paper›PMID 38162853›Full record

ArticleJGH open : an open access journal of gastroenterology and hepatology2023

A novel Monash Pouch diet in patients with an ileoanal pouch is tolerable and has favorable metabolic luminal effects.

Zaid S Ardalan, Chu K Yao, Kraig Green, Chris Probert, Paul A Gill, Sam Rosella, Jane G Muir, Miles P Sparrow, Peter R Gibson

Open access · goldAbstract read
In one paragraph

Article in JGH open : an open access journal of gastroenterology and hepatology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Zaid S ArdalanDepartment of Gastroenterology, Central Clinical School Monash University and Alfred Health Melbourne Victoria Australia.
Chu K YaoDepartment of Gastroenterology, Central Clinical School Monash University and Alfred Health Melbourne Victoria Australia.ORCID https://orcid.org/0000-0002-5301-2457
Kraig GreenDepartment of Molecular and Clinical Cancer Medicine University of Liverpool Liverpool UK.ORCID https://orcid.org/0009-0004-0589-7475
Chris ProbertDepartment of Molecular and Clinical Cancer Medicine University of Liverpool Liverpool UK.
Paul A GillDepartment of Gastroenterology, Central Clinical School Monash University and Alfred Health Melbourne Victoria Australia.
Sam RosellaDepartment of Gastroenterology, Central Clinical School Monash University and Alfred Health Melbourne Victoria Australia.
Jane G MuirDepartment of Gastroenterology, Central Clinical School Monash University and Alfred Health Melbourne Victoria Australia.
Miles P SparrowDepartment of Gastroenterology, Central Clinical School Monash University and Alfred Health Melbourne Victoria Australia.
Peter R GibsonDepartment of Gastroenterology, Central Clinical School Monash University and Alfred Health Melbourne Victoria Australia.ORCID https://orcid.org/0000-0001-9108-1712
Alfred Health · AUHealth First · USUniversity of Liverpool · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aims: To evaluate a whole-food diet strategy (the Monash Pouch diet [MPD]) designed based on the interacting roles dietary factors play with pouch health. Specifically, its tolerability and acceptability, whether it achieved its dietary and metabolic goals, and the effects on symptoms and inflammation were examined. Methods: In a 6-week open-label trial, patients with ileoanal pouches educated on the MPD were assessed regarding diet tolerability and acceptance, food intake (7-day food diaries), pouch-related symptoms (clinical pouchitis disease activity index), and, in 24-h fecal samples, calprotectin, fermentative biomarkers, and volatile organic compounds (VOC). Results: Of 12 patients, 6 male, mean (SD) age 55 (5) and pouch age 13 (2) years, one withdrew with partial small bowel obstruction. Tolerability was excellent in 9 (75%) and acceptance was high (81%). Targeted changes in dietary intake were achieved. Fecal branched- to short-chain fatty acid ratio increased by median 60 [IQR: 11-80]% ( Conclusion: Well tolerated and accepted, the MPD achieved targeted changes in intakes and fermentation of carbohydrates relative to that of protein. There were signals of improvement in symptoms. These results indicate the need for a randomized-controlled trial. (Trial registration: ACTRN12621000374864; https://www.anzctr.org.au/ACTRN12621000374864.aspx).

Indexed as

dietfermentable oligo‐, di‐ and monosaccharides and polyolspouchpouchitisprotein fermentationulcerative colitis

Identifiers

PMID38162853
PMCPMC10757501
OpenAlexW4389082205

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.